RE:RE:RE:Beacon lowers target to $12.25 cdnJomen wrote "In fact, Philips recall is a growth opportunity for Viemed both because they can bill more cash for multi-purpose vents"
That statement is incorrect. Research CMS replacement/substitute code. IE Yes you can bill for substitute equipment, but you can only bill the same amount for equipement you have replaced. Not more than that, regardless on the replacement equipment used.
Jomen wrote "So Philips to me can have either a neutral or positive outcome. While the OIG's outcome will be neutral (no cash lost or gained)"
That statement is incorrect. As per the company guidance and statements, the effect/results of the recall and OIG report are unknown at this time. The market does not like uncertainty. In limbo.
It is not surpising that Beacon lowered it's price target, as at least they are dealing with reality of the headwinds.
GLTA